查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1649446

血管成形术用气球市场：预测（2025-2030）

Angioplasty Balloons Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

血管成形术用气球市场预计将从 2025 年的 28.85 亿美元成长到 2030 年的 36.02 亿美元，预测期内的复合年增长率为 4.54%。

球囊血管成形术是一种用于打通狭窄或阻塞动脉的手术，被认为是一种微创手术。微创手术的成长对整个血管成形术用气球市场的扩张做出了巨大贡献。由于老龄化人口中心血管疾病 (CVD) 发病率上升以及生活方式相关风​​险因素增加，市场正在经历成长。心血管疾病是全球最大的死亡原因，良好的法规环境进一步推动血管成形术用气球市场的成长。此外，该领域不断涌现创新产品开发与应用。例如，欧盟统计局报告称，2022 年进行了 106 万例腔内冠状动脉成形术，成为欧洲心血管疾病患者的常见治疗方法。

血管成形术用气球市场驱动因素：

  • 心血管疾病发生率不断上升：心臟病发作时通常使用血管成形术来清除阻塞并恢復血流。具体来说，球囊血管成形术是一种利用球囊治疗心血管疾病的微创技术。每年心血管疾病夺走2,050多万人的生命，其中85%是由于心臟疾病（如心臟病）和脑血管疾病（如中风）。常见的风险因素包括吸烟、糖尿病、高胆固醇、不良饮食和高血压，在中低收入国家尤其常见。根据世界心臟日预测，到2023年，全球将有约6.2亿人患有心臟和循环系统疾病，每年新增病例约6,000万例。

血管成形术用气球市场的地理展望：

  • 亚太地区的快速成长：北美市场由于其先进的医疗保健系统、对心血管护理的强劲需求以及冠状动脉疾病 (CAD) 和周边动脉疾病(PAD) 发病率的上升而增长。这种需求主要由美国人口老化所推动，这大大增加了心血管疾病的可能性，而这种疾病需要透过血管成形术来清除阻塞的动脉。此外，技术的进步也促进了更复杂的球囊和导管的开发，从而提高了性能。

预计预测期内亚太地区将快速成长。印度和中国等国家由于人口增长和对医疗保健基础设施的日益重视，对血管成形术用气球的需求很高。总之，由于心血管疾病盛行率不断上升、医疗技术的进步以及各地区支持性的法规环境，血管成形术用气球市场预计将以显着的速度成长。随着医疗保健提供者寻求治疗心血管疾病的有效解决方案，对微创手术的需求持续增加。

为什么要购买这份报告？

  • 深刻分析：获得深入的市场洞察，涵盖主要和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 细分和区域分析，包括收益成长和预测国家
  • 公司概况（策略、产品、财务、主要发展等）

血管成形术用气球市场细分如下：

按类型

  • 普通气球
  • 药物释放型球囊
  • 球囊导管
  • 非顺应性球囊
  • 其他的

按应用

  • 週边设备
  • 冠状动脉

按最终用户产业

  • ASC
  • 医院
  • 导管室

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 其他的
  • 中东和非洲
  • UAE
  • 以色列
  • 其他的
  • 亚太地区
  • 中国
  • 日本
  • 韩国
  • 印度
  • 印尼
  • 台湾
  • 泰国
  • 其他的

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第 5 章血管成形术用气球市场（按类型）

  • 介绍
  • 普通气球
  • 药物释放型球囊
  • 球囊导管
  • 不合规球囊
  • 其他的

第六章血管成形术用气球市场（依应用）

  • 介绍
  • 週边设备
  • 冠状动脉

第 7 章血管成形术用气球市场（依最终用户划分）

  • 介绍
  • ASCs
  • 医院
  • 导管室

第 8 章血管成形术用气球市场（按地区）

  • 介绍
  • 北美洲
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家
  • 南美洲
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家
  • 欧洲
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家
  • 中东和非洲
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家
  • 亚太地区
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Infinity Angioplasty Balloon
  • Poba Medical
  • Boston Scientific
  • Philips
  • Concept Medical
  • Lepu Medical Technology Company
  • Terumo Interventional Systems
  • B. Braun
  • Medtronic
  • Conic Vascular
  • Abbott Laboratories.
  • AngioDynamics.
  • Becton
  • Dickinson and Company.
简介目录
Product Code: KSI061616263

The angioplasty balloons market is projected to grow at a CAGR of 4.54% over the forecast period, increasing from US$2.885 billion in 2025 to US$3.602 billion by 2030.

Balloon angioplasty is a procedure used to open narrowed or blocked arteries and is considered a minimally invasive surgery. The growth of minimally invasive procedures is significantly contributing to the overall expansion of the angioplasty balloons market. This market is witnessing growth due to the rising incidence of cardiovascular diseases (CVDs) among the aging population and increasing lifestyle-related risk factors. CVDs are the leading cause of death globally, and a favorable regulatory environment further supports the growth of the angioplasty balloons market. Additionally, innovative product developments and applications are emerging within this sector. For instance, Eurostat reported that there were 1.06 million transluminal coronary angioplasty procedures performed in 2022, making it a common intervention for patients with cardiovascular diseases in Europe.

Drivers of the Angioplasty Balloons Market:

  • Increasing Prevalence of Cardiovascular Diseases: Angioplasty is often used during heart attacks to clear blockages and restore blood flow. Balloon angioplasty, specifically, is a minimally invasive technique that utilizes a balloon to treat cardiovascular diseases. Each year, cardiovascular disease claims over 20.5 million lives, with 85% of these deaths attributed to coronary heart diseases (such as heart attacks) and cerebrovascular diseases (such as strokes). Common risk factors include smoking, diabetes, high cholesterol, poor diet, and hypertension, particularly prevalent in low- and middle-income countries. According to World Heart Day, around 620 million people globally were living with heart and circulatory diseases in 2023, with approximately 60 million new cases developing annually.

Geographical Outlook of the Angioplasty Balloons Market:

  • Exponential Growth in Asia Pacific: The North American market is experiencing growth due to its advanced healthcare system, strong demand for cardiovascular procedures, and increasing rates of coronary artery disease (CAD) and peripheral artery disease (PAD). This demand is largely driven by an aging population in the United States, where age significantly increases the likelihood of developing cardiovascular conditions that require angioplasty for clearing blocked arteries. Additionally, technological advancements have led to the development of more sophisticated balloons and catheters that enhance performance.

The Asia Pacific region is anticipated to witness rapid growth during the forecast period. Countries like India and China are experiencing significant demand for angioplasty balloons due to their growing populations and increasing focus on healthcare infrastructure. The rise in lifestyle-related health issues is also contributing to this trend.In summary, the angioplasty balloons market is poised for substantial growth driven by the increasing prevalence of cardiovascular diseases, advancements in medical technology, and supportive regulatory environments across various regions. The demand for minimally invasive procedures continues to rise as healthcare providers seek effective solutions for treating cardiovascular conditions.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Angioplasty Balloons Market has been segmented as following:

By Type

  • Normal Balloons
  • Drug-Eluting Balloons
  • Scoring Balloons
  • Non-Compliant Balloons
  • Others

By Application

  • Peripheral
  • Coronary

By End-User Industry

  • ASCs
  • Hospitals
  • Cath Labs

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Taiwan
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ANGIOPLASTY BALLOONS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Normal Balloons
  • 5.3. Drug-Eluting Balloons
  • 5.4. Scoring Balloons
  • 5.5. Non-Compliant Balloons
  • 5.6. Others

6. ANGIOPLASTY BALLOONS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Peripheral
  • 6.3. Coronary

7. ANGIOPLASTY BALLOONS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. ASCs
  • 7.3. Hospitals
  • 7.4. Cath Labs

8. ANGIOPLASTY BALLOONS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. UK
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Israel
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. India
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Taiwan
      • 8.6.4.7. Thailand
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Infinity Angioplasty Balloon
  • 10.2. Poba Medical
  • 10.3. Boston Scientific
  • 10.4. Philips
  • 10.5. Concept Medical
  • 10.6. Lepu Medical Technology Company
  • 10.7. Terumo Interventional Systems
  • 10.8. B. Braun
  • 10.9. Medtronic
  • 10.10. Conic Vascular
  • 10.11. Abbott Laboratories.
  • 10.12. AngioDynamics.
  • 10.13. Becton
  • 10.14. Dickinson and Company.